Accessibility

Feature

From Discovery to Market III - RID

From Discovery to Market III: Rapid Infection Diagnostics Inc.

The Commercialization Gap Is Real: Rapid Infection Diagnostics Shows Why Early Investment Matters   For most startups, securing enough capital to move from research to commercialization is one of the greatest challenges they will face. For Alberta-based Rapid Infection Diagnostics Inc. (RID), that journey has taken more than a decade, required nearly $20 million in […]

From Discovery to Market III: Rapid Infection Diagnostics Inc. Read More »

Connecting New Business Grads With Genomics Innovators

Genomic tools and technologies have the potential to improve our health, environment and nutrition, and Alberta has no shortage of entrepreneurs ready to meet the challenge. However, while biotech startups are typically well-equipped to test and refine their technologies and products, scaling-up into a sustainable business presents a wholly new challenge. A 2025 survey conducted

Connecting New Business Grads With Genomics Innovators Read More »

From Discovery to Market II: Nova Medical Testing Inc.

From Lab Discovery to Global Impact: How Nova Medical Testing Inc. is Advancing Metabolomics in Alberta and Beyond   In the world of life sciences, timing is everything. While genomics can help predict what might happen in the body, metabolomics reveals what has already happened and provides a powerful perspective that is becoming increasingly important

From Discovery to Market II: Nova Medical Testing Inc. Read More »

From Discovery to Market I: Luminous BioSolutions Inc.

Lighting the Way: A Calgary Startup Tackles One of Canada’s Biggest Environmental Challenges   In northern Alberta, one of the most complex environmental challenges in the world continues to grow quietly but persistently. More than a trillion litres of oil sands tailings water sit across vast landscapes, awaiting a viable path to treatment and eventual

From Discovery to Market I: Luminous BioSolutions Inc. Read More »

From Discovery to Market: Alberta Life Sciences Companies Creating Real Value

Alberta is in the midst of a transformation. Alongside the oil sands and the agricultural industries that have long defined its economy, a new sector is taking shape: a growing life sciences industry that is converting university research into patented technologies, commercialized products, and competitive companies with global reach. The numbers tell a compelling story,

From Discovery to Market: Alberta Life Sciences Companies Creating Real Value Read More »

Image on the left: Dr. David Wishart giving a speech at the podium. Image on the right: Dr. Wishart posing with the award with Gijs Gijs van Rooijen, Chief Scientific Officer, Genome Alberta

ASTech Award Honours Dr. David Wishart for World-Leading Contributions in AI/ML Innovation

As data becomes the engine driving modern discovery, Dr. David Wishart stands at the forefront in building the datasets and AI tools that use information to power innovation. A globally recognized leader in metabolomics and precision health, Dr. Wishart was honoured with the ASTech Award in the AI/ML Advancement and Application category, for his groundbreaking

ASTech Award Honours Dr. David Wishart for World-Leading Contributions in AI/ML Innovation Read More »

A group of friends smiling while hanging out outdoors

From Trial and Error to Optimized Care: How Genomics is Personalizing Mental Health Treatment

Many Albertans are impacted by mental health disorders or know a loved one who is. Mental health disorders are complex, with numerous genetic, social and environmental factors, and it can be hard to predict how a patient will respond to different medications or strategies. For some Albertans, finding a more direct path to an effective

From Trial and Error to Optimized Care: How Genomics is Personalizing Mental Health Treatment Read More »

Filippo Miglior receiving Genome Canada's Industry Collaboration Award

Pioneering Genomics in Dairy Farming: Dr. Filippo Miglior Receives Genome Canada’s Industry Collaboration Award

In a world increasingly attuned to the urgency of climate action, Dr. Filippo Miglior stands out for his contributions to sustainable agriculture. A trailblazer in dairy genomics, Dr. Miglior has been honored with Genome Canada’s Industry Collaboration Award for his groundbreaking work in dairy cattle genetics. Through the application of innovative genomic tools and building

Pioneering Genomics in Dairy Farming: Dr. Filippo Miglior Receives Genome Canada’s Industry Collaboration Award Read More »

Graphic of Double DNA Helix with Digital Overaly

Better Tools for Bigger Data – how AI and Machine Learning are Transforming Genomic Research

Artificial Intelligence (AI) and Machine Learning (ML) are big buzz words these days, and given their explosion into the public sphere, large language models like ChatGPT are often the first thing that comes to mind when we hear about AI. In reality, chatbots are only a small subset of the diverse technologies which fall under

Better Tools for Bigger Data – how AI and Machine Learning are Transforming Genomic Research Read More »

Scroll to Top
Share
Copy Link